Intracellular beta-thymosin-family peptide
Thymosin beta-4
Thymosin beta-4 denotes the full-length beta-thymosin peptide. Fragments sold or discussed under other names require their own identity documentation. Sharing a sequence region does not establish equivalence to the full molecule.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Activity in a model and assay conditions
Separate result and explanation. Activity under particular conditions does not define a specification for every material using the same name.
- Does the observation come from a cellular system, microorganism or whole organism?
- Are vehicle, medium and controls that may change the readout reported?
- Does the observed marker demonstrate the proposed mechanism or merely remain compatible with it?
Mechanism described in the literature
In biochemical experiments, thymosin beta-4 sequestered monomeric actin and prevented its normal incorporation into filaments. This is a biochemical finding, not a direct demonstration of tissue remodeling.
Other names in the literature
- Thymosin beta 4
- Tβ4
Actin complexes in cells
Human polymorphonuclear leukocyte experiments found that much of the monomeric actin was consistent with a thymosin beta-4 complex. Chemotactic stimulation changed the complex, but the assays did not support the conclusion that this necessarily reflected a loss of peptide affinity for actin (PMID 1447300).
Full-length peptide and tested fragments
Biochemical work compared the complete peptide with fragments generated by digestion. The tested fragments did not reproduce its effect on actin polymerization. The result does not cover every possible fragment, but it prevents functional equivalence from being inferred solely from a shared sequence region (PMID 8471179).
Keep the readout separate from the inferred variable
A DNase I assay provides an indirect readout of actin state. The enzyme signal, its interpretation and a downstream biological outcome are different levels of evidence. It should not be relabeled as a direct measurement of cell migration or tissue change.
Questions and answers
Does thymosin beta-4 automatically identify TB-500?
No. The full-length peptide's name does not document the molecular identity of a material labeled TB-500. Sequence and other identity evidence are needed.
Does a shared sequence region prove equivalent actin-related function?
No. Functional equivalence requires direct testing. The cited fragment comparison did not reproduce the full peptide's effect on actin polymerization.
Sources
- Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. — J Cell Biol, 1992
- Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes.
- Actin-sequestering ability of thymosin beta 4, thymosin beta 4 fragments, and thymosin beta 4-like peptides as assessed by the DNase I inhibition assay. — Biol Chem Hoppe Seyler, 1993
- Actin-sequestering ability of thymosin beta 4, thymosin beta 4 fragments, and thymosin beta 4-like peptides as assessed by the DNase I inhibition assay.